When treatment helps, but you're still making plans around a possible flare, there's more to discuss than the number of hives ...
Discover common skin care ingredients that can cause allergic reactions and learn how to identify them in your products. Chronic idiopathic urticaria, also known as chronic hives or chronic ...
A little over a year after landing its flagship approval in chronic hives, Novartis’ oral BTK inhibitor Rhapsido is expanding ...
The recent FDA approval of remibrutinib (Rhapsido) for symptomatic dermographism (SD) gives clinicians an on-label option for a condition long managed with off-label therapies, Raj Chovatiya, MD, PhD, ...
Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. Chronic spontaneous urticaria is very ...
Adam Friedman, MD: Hello, and welcome to Medscape Care Cues. I'm Dr Adam Friedman and I'm joined by my good friend and colleague, Dr Shawn Kwatra. Welcome, Shawn. Shawn G. Kwatra, MD: Thanks so much ...
Novartis' oral BTK inhibitor Rhapsido has had its label expanded in the US to include ​a second indication, symptomatic ...
PALO ALTO, Calif., April 15, 2025 /PRNewswire/ -- Evommune, Inc., a clinical stage biotechnology company discovering and developing new ways to treat immune-mediated inflammatory diseases, today ...
In Phase III RemIND trial, twice as many adults taking Rhapsido achieved complete hive resolution by Week 12 vs placebo, with ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Barzolvolimab prevents the binding of stem cell factor ...
In the 50-center international CURE study, diagnosis was delayed in 24.4% of the patients by at least a year. Pavel Kolkhir, MD, study lead and head of the chronic urticaria program in the Institute ...
Learn how cold urticaria causes hives, swelling and potentially severe reactions, plus how to recognize triggers, prevent ...